Immortalization of murine microglial cells by a v-raf / v-myc carrying retrovirus

https://doi.org/10.1016/0165-5728(90)90073-VGet rights and content

Abstract

A murine cell line (BV-2) has been generated by infecting primary microglial cell cultures with a -raf/v-myc oncogene carrying retrovirus (J2). BV-2 cells expressed nonspecific esterase activity, phagocytic ability and lacked peroxidase activity. Such cells secreted lysozyme and, following appropriate stimulation, also interleukin 1 and tumor necrosis factor. Furthermore, BV-2 cells exhibited spontaneous anti-Canada activity and acquired tumoricidal activity upon treatment with interferon-γ. Phenotypically, BV-2 cells resulted positive for MAC1 and MAC2 antigens, and negative for MAC3, glial fibrillary acidic protein (GFAP) and galactocerebroside (GC) antigens. Since BV-2 cells retain most of the morphological, phenotypical and functional properties described for freshly isolated microglial cells, we can conclude that J2 virus infection has resulted in the immortalization of active microglial cells.

References (33)

  • E. Blasi et al.

    Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor and interleukin 1

    Infect. Immun.

    (1990)
  • G.W. Cox et al.

    Heterogeneity of hematopoietic cells immoralized by v-raf/v-raf recombinant retrovirus infection of bone marrow or fetal liver

    J. Natl. Cancer Inst.

    (1989)
  • P. Del Rio Hortega

    Microglia

  • M.M. Esiri et al.

    Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglia cells in human brain

    J. Clin. Pathol.

    (1986)
  • K. Frei et al.

    Astrocyte derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages

    J. Immunol.

    (1986)
  • K. Frei et al.

    Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglia cells

    Eur. J. Immunol.

    (1987)
  • Cited by (886)

    View all citing articles on Scopus
    View full text